WashU leads new multi-omics production center for NIH research consortium

September 28, 2023

The National Institutes of Health (NIH) is channeling $50.3 million over the next five years into a new consortium dedicated to advancing the generation and analysis of multi-omics data for human health research. As part of this team, Washington University in St. Louis is establishing and will lead a central production center that functions as a hub for multi-omics analyses for materials from consortium members at each of six disease study sites identified by the NIH.

EMBA alum’s startup wins $250K in Texas competition

June 5, 2023

A WashU-based life sciences startup that patented a groundbreaking bloodstream marker that flags potential cardiovascular disease recently won a $250,000 investment prize in a major national pitch competition.

Wearable, light-based brain-imaging tech to be commercialized with aid of NIH grant

May 25, 2023

Wearable brain-imaging tech aims to reveal how the brain works in natural, realistic situations. Washington University faculty members Joseph P. Culver, Jason Trobaugh and Ed Richter, along with Adam Eggebrecht, have received a grant from the NIH to develop and commercialize a brain-imaging cap that uses LED light to gauge brain activity.

O’Brien team wins NIH prize to further develop maternal health device

January 24, 2023

Christine O’Brien, an assistant professor of biomedical engineering at the McKelvey School of Engineering at Washington University in St. Louis, and her team have received a $20,000 prize from the National Institutes of Health (NIH)’s Rapid Acceleration of Diagnostics Technology for Maternal Health Challenge.

New technology offers pathways to finding treatments for kidney disease

August 31, 2022

The search for effective treatments has been hampered because these highly structured cells cannot be cultured outside of the body, and because immortalized cell lines are not true to their structure. New research from Washington University’s McKelvey School of Engineering and the School of Medicine aims to overcome this critical barrier.

Salentra Biosciences

Salentra Biosciences

Mission is to use proprietary state-of-the-art SCIslet differentiation technology to make stem cell-derived islets accessible to diabetes researchers



Aims to diagnose autism early using machine learning to identify brain patterns

Viewing 1 - 10 of 23